Filtros de búsqueda

Lista de obras de Bertram Pitt

A Randomized Crossover Trial of Dietary Sodium Restriction in Stage 3-4 CKD.

artículo científico publicado en 2017

A history of systemic hypertension and incident heart failure hospitalization in patients with acute myocardial infarction and left ventricular systolic dysfunction

artículo científico publicado en 2009

A new HOPE for aldosterone blockade?

artículo científico publicado en 2004

A primer on aldosterone for gynecologists/obstetricians.

artículo científico publicado en 2007

A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure

scientific article published on June 2007

A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease

artículo científico publicado en 2016

A reappraisal of loop diuretic choice in heart failure patients

artículo científico publicado en 2015

A role for mineralocorticoid receptor blockade in the prevention of apoptosis

artículo científico publicado en 2005

ACCF/AHA consensus conference report on professionalism and ethics

artículo científico publicado en 2004

ACE inhibitors for patients with vascular disease without left ventricular dysfunction--may they rest in PEACE?

artículo científico publicado en 2004

Added benefit of mineralocorticoid receptor blockade in the primary prevention of sudden cardiac death

artículo científico publicado en 2007

Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: randomized and observational comparisons of secondary prevention trials and their meta-analyses

artículo científico publicado en 2004

Age and the effectiveness of anti-hypertensive therapy on improvement in diastolic function

artículo científico publicado en 2014

Aldosterone as a target in congestive heart failure ⬇️

artículo científico publicado el 1 de marzo de 2003

Aldosterone blockade in patients with acute myocardial infarction

artículo científico publicado en 2003

Aldosterone blockade in patients with chronic heart failure

artículo científico publicado en 2008

Aldosterone blockade in patients with heart failure and a reduced left ventricular ejection fraction

artículo científico publicado en 2009

Aldosterone blockade in patients with systolic left ventricular dysfunction

artículo científico publicado en 2003

Aldosterone blockade in post-acute myocardial infarction heart failure.

artículo científico publicado en 2006

Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity

artículo científico publicado en 2007

Aldosterone receptor antagonists for heart failure: current status, future indications.

artículo científico publicado en 2006

Aldosterone, ion channels, and sudden death: another piece of the circle?

artículo científico publicado en 2006

Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).

artículo científico

Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension

artículo científico publicado en 2005

Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study

artículo científico publicado en 2016

Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infar

artículo científico publicado en 2018

Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study

scientific article published on 01 December 2018

Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes

artículo científico publicado en 2017

Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk My

artículo científico publicado en 2016

Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative

artículo científico publicado en 2017

Association of obesity and survival in systolic heart failure after acute myocardial infarction: potential confounding by age

artículo científico publicado en 2010

Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study

artículo científico publicado en 2011

Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients

artículo científico publicado en 2008

Biomarker-guided therapies in heart failure: a forum for unified strategies

artículo científico publicado en 2013

Biomarkers of extracellular matrix turnover.

artículo científico publicado en 2009

Candesartan reduced mortality and hospital admissions in chronic heart failure.

artículo científico publicado en 2004

Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure.

artículo científico publicado en 2005

Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy

artículo científico publicado en 2016

Cardiovascular drug development: is it dead or just hibernating?

artículo científico

Cardiovascular events during differing hypertension therapies in patients with diabetes

artículo científico publicado en 2010

Cardiovascular protection for all individuals at high risk: evidence-based best practice

scientific article published on 23 August 2008

Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval

artículo científico publicado en 2007

Challenges to Data Monitoring Committees When Regulatory Authorities Intervene

artículo científico publicado en 2016

Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure

artículo científico publicado en 2017

Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study

artículo científico publicado en 2013

Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial

artículo científico publicado en 2015

Clinical outcomes according to QRS duration and morphology in the Eplerenone in Mild Patients: Hospitalization and SurvIval Study in Heart Failure (EMPHASIS-HF).

artículo científico publicado en 2015

Clinical trials of angiotensin receptor blockers in heart failure: what do we know and what will we learn?

artículo científico publicado en 2002

Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study).

artículo científico

Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study (ELITE II).

artículo científico publicado en 2005

Complete renin-angiotensin-aldosterone system (RAAS) blockade in high-risk patients: recent insights from renin blockade studies

artículo científico

Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure

artículo científico publicado en 2015

Contemporary Drug Development in Heart Failure: Call for Hemodynamically Neutral Therapies

artículo científico publicado en 2015

Coronary angiographic changes in patients with cardiac events in the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT).

artículo científico publicado en 2002

Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure

artículo científico publicado en 2005

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms

artículo científico publicado en 2014

Current Controlled Trials in Cardiovascular Medicine: a new journal for a new age (http://cvm.controlled-trials.com)

artículo científico publicado en 2000

Current medical management of stable coronary artery disease before and after elective percutaneous coronary intervention

artículo científico publicado en 2013

Cyclooxygenase-2 inhibition and cardiovascular events

artículo científico publicado en 2002

Declining Risk of Sudden Death in Heart Failure

artículo científico publicado en 2017

Decongestion in acute heart failure

artículo científico publicado en 2014

Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Stud

artículo científico publicado en 2011

Developing therapies for heart failure with preserved ejection fraction: current state and future directions

artículo científico publicado en 2014

Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

artículo científico publicado en 2012

Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction

artículo científico publicado en 2019

Diuretic use, progressive heart failure, and death in patients in the DIG study

artículo científico publicado en 2006

Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

artículo científico publicado en 2003

Do diuretics and aldosterone receptor antagonists improve ventricular remodeling?

artículo científico publicado en 2002

Drospirenone for oral contraception and hormone replacement therapy: are its cardiovascular risks and benefits the same as other progestogens?

artículo científico publicado en 2007

Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial

scientific article published on 08 August 2019

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study

artículo científico publicado en 2014

Economic evaluation of the randomized aldactone evaluation study (RALES): treatment of patients with severe heart failure

artículo científico publicado en 2002

Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors

artículo científico publicado en 2017

Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial

artículo científico

Effect of Patiromer on Urinary Ion Excretion in Healthy Adults

artículo científico publicado en 2016

Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial

artículo científico

Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies

artículo científico publicado en 2004

Effect of aliskiren in patients with heart failure according to background dose of ACE inhibitor: a retrospective analysis of the Aliskiren Observation of Heart Failure Treatment (ALOFT) trial

artículo científico publicado en 2011

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

artículo científico publicado en 1991

Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial

artículo científico publicado en 2017

Effect of eplerenone in percutaneous coronary intervention-treated post-myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS trial

Effect of eplerenone on extracellular cardiac matrix biomarkers in patients with acute ST-elevation myocardial infarction without heart failure: insights from the randomized double-blind REMINDER Study

artículo científico publicado en 2017

Effect of intensive versus standard blood pressure lowering on diastolic function in patients with uncontrolled hypertension and diastolic dysfunction

artículo científico publicado en 2009

Effect of losartan in aging-related endothelial impairment

artículo científico publicado en 2002

Effect of patiromer on reducing serum potassium and preventing recurrent hyperkalaemia in patients with heart failure and chronic kidney disease on RAAS inhibitors

artículo científico publicado en 2015

Effect of spironolactone on 30-day death and heart failure rehospitalization (from the COACH Study).

artículo científico publicado en 2014

Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial

artículo científico publicado en 2008

Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial

artículo científico publicado en 2003

Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial ⬇️

artículo científico publicado el 6 de diciembre de 2012

Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial

artículo científico publicado en 2007

Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women

artículo científico publicado en 2005

Effects of enalapril in systolic heart failure patients with and without chronic kidney disease: insights from the SOLVD Treatment trial

artículo científico publicado en 2012

Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study

artículo científico publicado en 2003

Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure

artículo científico publicado en 2008

Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension

artículo científico publicado en 2007

Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future

artículo científico publicado en 2016

Emerging cardiovascular indications of mineralocorticoid receptor antagonists

artículo científico publicado en 2015

Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study

artículo científico publicado en 2012

Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).

artículo científico publicado en 2012

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms ⬇️

artículo científico publicado el 14 de noviembre de 2010

Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations

artículo científico

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

artículo científico publicado en 2005

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

artículo científico publicado en 2003

Eplerenone: is it time to add this drug to current heart failure therapy? ⬇️

artículo científico publicado el 1 de enero de 2012

Eplerenone: will it have a role in the treatment of acute coronary syndromes?

artículo científico publicado en 2004

Erratum: Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease

artículo científico publicado en 2013

Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease

artículo científico publicado en 2018

Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction <or=30%.

artículo científico publicado en 2006

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial ⬇️

artículo científico publicado el 5 de enero de 2011

Expanding the outcomes in clinical trials of heart failure: the quality of life and economic components of EPHESUS (EPlerenone's neuroHormonal Efficacy and SUrvival Study).

artículo científico publicado en 2002

Expert Panel Recommendations for the Identification and Management of Hyperkalemia and Role of Patiromer in Patients with Chronic Kidney Disease and Heart Failure

artículo científico publicado en 2017

Expert consensus document: Mitochondrial function as a therapeutic target in heart failure

scientific article published on 22 December 2016

Exploring New Endpoints for Patients With Heart Failure With Preserved Ejection Fraction

artículo científico publicado en 2016

Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Stu

artículo científico publicado en 2009

Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry

artículo científico publicado en 2018

Generic drugs in cardiology: will they reduce health care costs?

artículo científico publicado en 2004

Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis

artículo científico publicado en 2012

Geographic variation in heart failure trials: time for scepticism?

artículo científico publicado en 2014

Globalization of cardiovascular clinical research: the balance between meeting medical needs and maintaining scientific standards

artículo científico

Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial

artículo científico publicado en 2004

Heart Failure Clinical Trials in East and Southeast Asia: Understanding the Importance and Defining the Next Steps

artículo científico publicado en 2016

Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition

artículo científico publicado en 2008

Heart failure: the role for mineralocorticoid receptor antagonists

artículo científico

History of hypertension and eplerenone in patients with acute myocardial infarction complicated by heart failure

artículo científico publicado en 2008

Hyperkalemia in Heart Failure

artículo científico publicado en 2016

Hyperuricaemia, chronic kidney disease, and outcomes in heart failure: potential mechanistic insights from epidemiological data

artículo científico publicado en 2011

Hypo- and hyperglycemia predict outcome in patients with left ventricular dysfunction after acute myocardial infarction: data from EPHESUS.

artículo científico publicado en 2012

Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies

artículo científico publicado en 2010

Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure ⬇️

artículo científico publicado el 9 de marzo de 2011

Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia

Implications of geographical variation on clinical outcomes of cardiovascular trials

artículo científico publicado en 2012

Improving cardiovascular clinical trials conduct in the United States: recommendation from clinicians, researchers, sponsors, and regulators

artículo científico publicado en 2014

Improving outcomes in post-acute myocardial infarction heart failure: incorporation of aldosterone blockade into combination therapy to optimize neurohormonal blockade

artículo científico publicado en 2006

Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: result

artículo científico

Incident Hyperkalemia, Hypokalemia, and Clinical Outcomes During Spironolactone Treatment of Heart Failure With Preserved Ejection Fraction: Analysis of the TOPCAT Trial

artículo científico publicado en 2018

Increased cardiovascular risk associated with non-cardiac chest pain in patients with a prior psychiatric hospitalization: an opportunity and challenge for both the psychiatrist and the cardiologist ⬇️

artículo científico publicado el 1 de enero de 2011

Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study).

artículo científico publicado en 2012

Influence of ejection fraction on cause-specific mortality in heart failure with preserved ejection fraction

artículo científico publicado en 2017

Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial

artículo científico publicado en 2017

Learning from recent trials and shaping the future of acute heart failure trials

artículo científico publicado en 2013

Lipid levels after acute coronary syndromes

artículo científico

Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the PROFILE Trial After 24 Years

artículo científico publicado en 2017

Loop diuretics in patients with heart failure: time to change to torsemide?

artículo científico publicado en 2009

Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensity-matched study

artículo científico publicado en 2008

Low-density lipoprotein cholesterol in patients with stable coronary heart disease--is it time to shift our goals?

artículo científico publicado en 2005

MRAs in Patients With AMI Without Early Evidence of Heart Failure: Time for Reappraisal?

artículo científico publicado en 2016

Magnetic resonance imaging left ventricular mass reduction with fixed-dose angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertension

artículo científico publicado en 2009

Male gender, diabetes, COPD, anemia, and creatinine clearance < 30 mL/min predicted hospitalization after heart failure diagnosis

artículo científico publicado en 2010

Maximizing scientific knowledge from randomized clinical trials

artículo científico publicado en 2010

Medical Care Costs and Quality of Life after Randomization to Coronary Angioplasty or Coronary Bypass Surgery

article

Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease

artículo científico publicado en 2004

Medical therapy versus percutaneous coronary interventions for patients with stable and unstable coronary artery disease

artículo científico publicado en 2008

Midcourse correction to a clinical trial when the event rate is underestimated: the Look AHEAD (Action for Health in Diabetes) Study ⬇️

artículo científico publicado el 1 de febrero de 2012

Mild hyperkalemia and outcomes in chronic heart failure: a propensity matched study

artículo científico publicado en 2009

Mineralocorticoid Receptor Antagonists in High-Risk Heart Failure Patients With Diabetes Mellitus and/or Chronic Kidney Disease

artículo científico publicado en 2017

Mineralocorticoid receptor antagonism in experimental atherosclerosis

artículo científico publicado en 2002

Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes ⬇️

artículo científico publicado el 14 de junio de 2011

Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice

artículo científico publicado en 2012

Mineralocorticoid receptor antagonists in patients with acute myocardial infarction - A systematic review and meta-analysis of randomized trials

artículo científico publicado en 2017

Mineralocorticoid receptor antagonists in patients with heart failure: current experience and future perspectives

artículo científico publicado en 2016

Mineralocorticoid receptor blockade: new insights into the mechanism of action in patients with cardiovascular disease ⬇️

artículo científico publicado el 1 de septiembre de 2003

Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups ⬇️

artículo científico publicado el 8 de abril de 2011

Moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor blocker monotherapy ⬇️

artículo científico publicado el 1 de enero de 2011

Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling

artículo científico publicado en 2009

Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction

artículo científico publicado en 2008

Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much?

artículo científico publicado en 2009

Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study

artículo científico publicado en 2011

New Opportunities and Challenges for Clinical Application of mIBG Imaging ⬇️

artículo científico publicado el 1 de septiembre de 2010

New approaches to hyperkalemia in patients with indications for renin angiotensin aldosterone inhibitors: Considerations for trial design and regulatory approval

artículo científico publicado en 2016

New insights into the role of aldosterone in cardiorenal disease and the clinical implications. Introduction

artículo científico publicado en 2002

New potassium binders for the treatment of hyperkalemia: current data and opportunities for the future

artículo científico publicado en 2015

Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction

artículo científico publicado en 2014

Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched study

artículo científico publicado en 2009

Outcomes in younger and older adults with chronic advanced systolic heart failure: A propensity-matched study ⬇️

artículo científico publicado el 14 de octubre de 2010

PEARL-HF: Prevention of Hyperkalemia in Patients With Heart Failure Using a Novel Polymeric Potassium binder, RLY5016 ⬇️

artículo científico publicado el 1 de enero de 2012

Patient selection in heart failure with preserved ejection fraction clinical trials

artículo científico publicado en 2015

Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors

artículo científico publicado en 2014

Patiromer induces rapid and sustained potassium lowering in patients with chronic kidney disease and hyperkalemia

artículo científico publicado en 2015

Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.

artículo científico publicado en 2012

Pharmacotherapy: Cardiovascular effects of aldosterone blockade in CKD.

artículo científico publicado en 2009

Photothermolysis of sebaceous glands in human skin ex vivo with a 1,708 nm Raman fiber laser and contact cooling ⬇️

artículo científico publicado el 1 de agosto de 2011

Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT).

artículo científico publicado en 2002

Potassium Homeostasis in Health and Disease: A Scientific Workshop Cosponsored by the National Kidney Foundation and the American Society of Hypertension

artículo científico publicado en 2017

Potassium homeostasis in health and disease: A scientific workshop cosponsored by the National Kidney Foundation and the American Society of Hypertension

artículo científico publicado en 2017

Potassium lowering agents: Recommendations for physician and patient education, treatment reappraisal, and serial monitoring of potassium in patients with chronic hyperkalemia

artículo científico publicado en 2016

Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study

artículo científico publicado en 2008

Predictors of contemporary coronary artery bypass grafting outcomes

artículo científico publicado en 2014

Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients

artículo científico publicado en 2018

Professor Bertram Pitt on therapy of heart failure after EMPHASIS. "Clear prognosis improvement" (interview by Dr. Med. Dirk Enecke)

artículo científico publicado en 2010

Prognostic Value of Estimated Plasma Volume in Heart Failure

artículo científico publicado en 2015

Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial).

artículo científico publicado en 2016

QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection Fraction

artículo científico publicado en 2016

QT dispersion has no prognostic value in patients with symptomatic heart failure: an ELITE II substudy

artículo científico publicado en 2003

Race Influences the Safety and Efficacy of Spironolactone in Severe Heart Failure ⬇️

artículo científico publicado el 12 de agosto de 2013

Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial

artículo científico publicado en 2018

Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction

artículo científico publicado en 2010

Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease

artículo científico publicado en 2012

Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney diseas

artículo científico publicado en 2015

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).

artículo científico publicado en 2010

Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized, controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction ⬇️

artículo científico publicado el 8 de noviembre de 2011

Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line comb

artículo científico publicado en 2004

Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data

artículo científico publicado en 2017

Recent advances in pharmacological treatments of hyperkalemia: focus on patiromer

artículo científico publicado en 2016

Relation of High Serum Bilirubin to Short-Term Mortality Following a Myocardial Infarction Complicated by Left Ventricular Systolic Dysfunction (from the High-Risk Myocardial Infarction Database Initiative).

artículo científico publicado en 2018

Relation of circulating cardiac myosin light chain 1 isoform in stable severe congestive heart failure to survival and treatment with flosequinan

artículo científico publicado en 2002

Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myoc

artículo científico publicado en 2016

Renal outcomes in hypertensive Black patients at high cardiovascular risk ⬇️

artículo científico publicado el 21 de diciembre de 2011

Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial

artículo científico publicado en 2010

Response to: Hyperkalaemia in heart failure: binding the patient to improved treatment?

artículo científico publicado en 2015

Revascularization in patients with chronic kidney disease: the state of the ARTS.

artículo científico publicado en 2005

Review: remote patient monitoring of patients with heart failure reduces mortality and heart failure admissions

artículo científico publicado en 2010

Role of High-Dose Beta-Blockers in Patients with Heart Failure with Preserved Ejection Fraction and Elevated Heart Rate

article by Phillip H. Lam et al published 1 August 2018 in American Journal of Medicine

Role of aldosterone blockade for treatment of heart failure and post-acute myocardial infarction

artículo científico publicado en 2006

Role of aldosterone blockade in heart failure

artículo científico publicado en 2005

Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function

article

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

artículo científico publicado en 2013

Selection of a mineralocorticoid receptor antagonist for patients with hypertension or heart failure

artículo científico

Serum Chloride and Sodium Interplay in Patients With Acute Myocardial Infarction and Heart Failure With Reduced Ejection Fraction: An Analysis From the High-Risk Myocardial Infarction Database Initiative

artículo científico publicado en 2017

Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS).

artículo científico publicado en 2008

Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study

artículo científico publicado en 2010

Serum potassium in patients with chronic heart failure: once we make a U-turn where should we go?

artículo científico publicado en 2017

Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High-Risk Myocardial Infarction Database Initiative.

artículo científico publicado en 2015

Should chronic heart failure patients with reduced left-ventricular ejection fraction receive angiotensin-receptor blockers?

artículo científico publicado en 2005

Similar clinical benefits from below-target and target dose enalapril in patients with heart failure in the SOLVD Treatment trial.

artículo científico publicado en 2017

Sodium and Fluid Excretion With Torsemide in Healthy Subjects is Limited by the Short Duration of Diuretic Action

artículo científico publicado en 2017

Soluble guanylate cyclase: a potential therapeutic target for heart failure

artículo científico publicado en 2013

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease

artículo científico publicado en 2020

Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

artículo científico publicado en 2020

Spironolactone Metabolites in TOPCAT - New Insights into Regional Variation

artículo científico publicado en 2017

Spironolactone for heart failure with preserved ejection fraction

artículo científico publicado en 2014

Spironolactone treatment and clinical outcomes in patients with systolic dysfunction and mild heart failure symptoms: a retrospective analysis

artículo científico publicado en 2006

Statin use and survival in patients with chronic heart failure--results from two observational studies with 5200 patients

artículo científico publicado en 2006

Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside

artículo científico publicado en 2016

Stroke Risk in Patients With Reduced Ejection Fraction After Myocardial Infarction Without Atrial Fibrillation

artículo científico publicado en 2018

Sudden death in patients with myocardial infarction

artículo científico publicado en 2005

Tailoring mineralocorticoid receptor antagonist therapy in heart failure patients: are we moving towards a personalized approach?

artículo científico publicado en 2017

Task force 2: Investigator participation in clinical research

artículo científico publicado en 2004

Teasing Apart Heart Failure With Preserved Ejection Fraction Phenotypes With Echocardiographic Imaging: Potential Approach to Research and Clinical Practice

artículo científico publicado en 2018

The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus

artículo científico publicado en 2005

The Role of Mineralocorticoid Receptor Antagonists in Patients with American College of Cardiology/American Heart Association Stage B Heart Failure ⬇️

artículo científico publicado el 14 de diciembre de 2011

The Seattle Heart Failure Model: prediction of survival in heart failure

artículo científico publicado en 2006

The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunction

artículo científico publicado en 2013

The burden of proof: The current state of atrial fibrillation prevention and treatment trials

artículo científico publicado en 2017

The collateral circulation of the heart

artículo científico publicado en 2013

The detection of myocardial fibrosis: an opportunity to reduce cardiovascular risk in patients with diabetes mellitus?

artículo científico publicado en 2012

The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction

artículo científico publicado en 2009

The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial

artículo científico publicado en 2013

The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patients

artículo científico publicado en 2013

The impact of the coronary collateral circulation on mortality: a meta-analysis

artículo científico

The measurement of plasma aldosterone in patients post-myocardial infarction

artículo científico publicado en 2008

The past, present and future of renin-angiotensin aldosterone system inhibition

artículo científico publicado en 2012

The relationship between anemia, change in hematocrit over time and change in health status in patients with heart failure after myocardial infarction

artículo científico publicado en 2008

The role of aldosterone blockade in end-stage renal disease

artículo científico publicado en 2009

The role of aldosterone blockade in patients with heart failure

artículo científico publicado en 2005

The role of ambulatory blood pressure monitoring compared with clinic and home blood pressure measures in evaluating moderate versus intensive treatment of hypertension with amlodipine/valsartan for patients uncontrolled on angiotensin receptor bloc

artículo científico publicado el 1 de abril de 2011

The role of chlorthalidone in patients with high-risk hypertension

artículo científico publicado en 2009

The role of mineralocorticoid receptor antagonists (MRAs) in very old patients with heart failure

artículo científico publicado el 1 de septiembre de 2012

The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure

artículo científico publicado en 2016

The tolerability and safety profile of patiromer: a novel polymer-based potassium binder for the treatment of hyperkalemia

artículo científico publicado en 2018

Time to retrieve the best benefits from renin angiotensin aldosterone system (RAAS) inhibition in heart failure patients with reduced ejection fraction: lessons from randomized controlled trials and registries

artículo científico publicado en 2014

Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial

artículo científico publicado en 2009

Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity-matched study of the EPHESUS trial

artículo científico publicado en 2009

Trends in Treatment for Patients Hospitalized with Heart Failure with Preserved Ejection Fraction Before and After Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT)

scientific article published on 14 March 2020

Triglycerides and cardiovascular events in ACS: the need for combined lipid-altering therapies

artículo científico publicado en 2008

True rate of mineralocorticoid receptor antagonists-related hyperkalemia in placebo-controlled trials: A meta-analysis

artículo científico publicado en 2017

Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials

artículo científico

When to stop a clinical trial early for benefit: lessons learned and future approaches

artículo científico

Withdrawal of cerivastatin from the world market

artículo científico publicado en 2001

Would you give a beta-blocker and/or aldosterone antagonist to a patient with an ejection fraction (EF) of 30 who has never had symptoms of heart failure?

artículo científico publicado en 2005

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda